In August, we added 115 citations in DIDB, including 47 in vitro (with 28 articles published in August 2024) and 68 in vivo articles (with 38 articles published in August 2024).
2 NDA/BLAs approved in 2024, including elafibranor (IQIRVO) and donanemab (KISUNLA), were also curated in DIDB.
You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.
As always, feel free to contact us if you have any questions or comments.